Invesco Ltd. Poly Pid Ltd. Transaction History

Invesco Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$4.35 - $5.76 $88,100 - $116,657	-20,253 Reduced 65.48%	10,675 $50,000
Q1 2022 May 16, 2022	SELL	$3.92 - $6.25 $2,842 - $4,531	-725 Reduced 2.29%	30,928 $169,000
Q4 2021 Feb 14, 2022	BUY	$5.52 - $8.42 $58,318 - $88,957	10,565 Added 50.1%	31,653 $182,000
Q3 2021 Nov 15, 2021	SELL	$7.05 - $9.48 $21,368 - $28,733	-3,031 Reduced 12.57%	21,088 $164,000
Q2 2021 Aug 17, 2021	SELL	$8.4 - $9.99 $507,880 - $604,015	-60,462 Reduced 71.48%	24,119 $218,000
Q1 2021 May 17, 2021	BUY	$8.92 - $15.5 $464,830 - $807,720	52,111 Added 160.49%	84,581 $775,000
Q4 2020 Feb 16, 2021	BUY	$8.89 - $13.5 $288,658 - $438,345	32,470 New	32,470 $321,000

Ticker PYPD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,551,200
Market Cap $64.5M
Description
PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well a...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.